Top compounds associated with response to CLTA


Feature Type Standardized
Nominal ANOVA
mRNA Tamoxifen CTRPv2 pan-cancer AAC -0.087 0.02
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC -0.11 0.02
mRNA Bortezomib FIMM pan-cancer AAC 0.33 0.02
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.086 0.02
mRNA PDMP CTRPv2 pan-cancer AAC -0.085 0.03
mRNA phloretin CTRPv2 pan-cancer AAC -0.077 0.03
mRNA Imatinib CTRPv2 pan-cancer AAC -0.081 0.03
mRNA CEP-701 GDSC1000 pan-cancer AAC 0.073 0.03
mRNA Panobinostat CTRPv2 pan-cancer AAC -0.074 0.03
mRNA Midostaurin GDSC1000 pan-cancer AAC 0.075 0.03
Download CSV